4
Changes in Ownership
Cellectar Biosciences, Inc. Filed Acc 0001104659-24-072885
Options or other derivatives
- Chief Commercial Officer acquired 260,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Lea Darrell Shane Chief Commercial Officer | 2024-06-14 | Grant or award · Stock option (right to buy) | +260,000 | 260,000 | D | ||
Loading xslF345X05/tm2417520-6_4seq1.xml…